Zhejiang Shouxiangu Pharmaceutical Co (SHSE:603896) Total Long-Term Assets: ¥1,808.6 Mil (As of Jun. 2026)

Author:

Vera Yuan

Director of Data and Quant Analytics at GuruFocus

Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.

View Profile →

Reviewed by:

Charlie Tian

Founder & CEO of GuruFocus

Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

View Profile →

Zhejiang Shouxiangu Pharmaceutical Co Ltd SHSE:603896

64 GF Score

Price ¥14.92

GF Value ¥21.35

Valuation Possible Value Trap

4 Warning Signs

View Full Analysis

Start Your Free 7-Day GuruFocus Premium Trial

Unlock 30-Y financials, GF Score, and 150+ pro screeners →

What is Zhejiang Shouxiangu Pharmaceutical Co Total Long-Term Assets?

Zhejiang Shouxiangu Pharmaceutical Co SHSE:603896 -2.99% 64 Total Long-Term Assets is ¥1,808.6 Mil as of Jun. 2026. GuruFocus rates SHSE:603896 with a GF Score™ of 64/100 and a GF Value™ of ¥21.35 (Possible Value Trap). The stock has 4 warning signs investors should review.

Total Long-Term Assets includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets. Zhejiang Shouxiangu Pharmaceutical Co's Total Long-Term Assets for the quarter that ended in Jun. 2026 was ¥1,808.6 Mil.

Try GuruFocus Premium free for 7 days

Unlock GF Score, GF Value, 30-Y financials, and pro screeners.

Get Started →

Zhejiang Shouxiangu Pharmaceutical Co Total Long-Term Assets Related Terms

Zhejiang Shouxiangu Pharmaceutical Co Total Long-Term Assets Historical Data

* Premium members only.

The historical data trend for Zhejiang Shouxiangu Pharmaceutical Co's Total Long-Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zhejiang Shouxiangu Pharmaceutical Co Total Long-Term Assets Chart

Zhejiang Shouxiangu Pharmaceutical Co Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Total Long-Term Assets

Get a 7-Day Free Trial

917.16

994.18

1,367.51

1,611.15

1,810.98

Zhejiang Shouxiangu Pharmaceutical Co Quarterly Data
	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26	Jun26
Total Long-Term Assets	Get a 7-Day Free Trial															1,721.41	1,717.92	1,810.98	1,803.35	1,808.62

64GF Score

Zhejiang Shouxiangu Pharmaceutical Co Ltd SHSE:603896

Total Long-Term Assets is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Start Your Free 7-Day GuruFocus Premium Trial

Unlock 30-Y financials, GF Score, and 150+ pro screeners →

Zhejiang Shouxiangu Pharmaceutical Co Total Long-Term Assets Calculation

Total Long-Term Assets are the sum of the carrying amounts of all assets that are expected to be realized in cash, sold or consumed longer than one year. It includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets.

Frequently Asked Questions Learn more about Total Long-Term Assets →

What does a Total Long-Term Assets of ¥1,808.6 Mil mean?

Zhejiang Shouxiangu Pharmaceutical Co (SHSE:603896) has a Total Long-Term Assets of ¥1,808.6 Mil as of Jun. 2026. Total Long-Term Assets are assets that are expected to be realized in cash, sold or consumed longer than one year. View historical data on Zhejiang Shouxiangu Pharmaceutical Co and its competitors.

Is Zhejiang Shouxiangu Pharmaceutical Co's Total Long-Term Assets too high?

Zhejiang Shouxiangu Pharmaceutical Co's current Total Long-Term Assets is ¥1,808.6 Mil. Overall, Zhejiang Shouxiangu Pharmaceutical Co has a GF Score™ of 64/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.

How does Zhejiang Shouxiangu Pharmaceutical Co's Total Long-Term Assets compare to VRTX and REGN?

Zhejiang Shouxiangu Pharmaceutical Co's Total Long-Term Assets of ¥1,808.6 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Total Long-Term Assets for a Biotechnology company?

A good Total Long-Term Assets depends on the Biotechnology industry context. However, Total Long-Term Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Total Long-Term Assets mean?

A high Total Long-Term Assets can signal that a stock is expensive relative to its fundamentals. Total Long-Term Assets are assets that are expected to be realized in cash, sold or consumed longer than one year. View historical data on Zhejiang Shouxiangu Pharmaceutical Co and its competitors. Zhejiang Shouxiangu Pharmaceutical Co's current Total Long-Term Assets is ¥1,808.6 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Zhejiang Shouxiangu Pharmaceutical Co stock overvalued right now?

Based on GuruFocus' analysis, Zhejiang Shouxiangu Pharmaceutical Co (SHSE:603896) is currently considered Possible Value Trap. The stock's GF Value™ is ¥21.35, compared to a current price of ¥14.92 — trading 30.1% below its estimated fair value. The current Total Long-Term Assets is ¥1,808.6 Mil. Zhejiang Shouxiangu Pharmaceutical Co's overall GF Score™ is 64/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Total Long-Term Assets calculated?

Total Long-Term Assets is calculated from a company's financial statements. For Zhejiang Shouxiangu Pharmaceutical Co (SHSE:603896), the current Total Long-Term Assets is ¥1,808.6 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Zhejiang Shouxiangu Pharmaceutical Co (SHSE:603896) Overvalued in 2026?

Based on GuruFocus' analysis, Zhejiang Shouxiangu Pharmaceutical Co stock appears to be undervalued. The current stock price of ¥14.92 is trading 30.1% below its estimated GF Value™ of ¥21.35. GuruFocus considers Zhejiang Shouxiangu Pharmaceutical Co to be Possible Value Trap.

Key valuation signals for SHSE:603896:

Total Long-Term Assets: ¥1,808.6 Mil
GF Value™: ¥21.35 vs. price of ¥14.92 (30.1% below fair value)
GF Score™: 64/100 with 4 warning signs

No single metric tells the full story. See the SHSE:603896 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Start Your Free 7-Day GuruFocus Premium Trial

Unlock 30-Y financials, GF Score, and 150+ pro screeners →